Sponsor: BioNTech SE, Collaborator: Pfizer, Information provided by (Responsible Party): BioNTech SE
Estimated Study Completion Date : May 2, 2023
https://clinicaltrials.gov/ct2/show/nct04368728

Sponsor: ModernaTX, Inc., Collaborator: Merck Sharp & Dohme Corp., Information provided by (Responsible Party): ModernaTX, Inc.
Estimated Study Completion Date : June 30, 2024
https://clinicaltrials.gov/ct2/show/nct03897881

Sponsor: AstraZeneca, Collaborator: Iqvia Pty Ltd, Information provided by (Responsible Party): AstraZeneca.
Estimated Study Completion Date : February 14, 2023
https://clinicaltrials.gov/ct2/show/nct04516746